Endogenous expression of B7-H4 improves long-term murine islet allograft survival

Transplantation

Volumn 95, Issue 1, 2013, Pages 94-99

  Wang, Xiaojie ^a   Hao, Jianqiang ^a   Metzger, Daniel L ^a   Mui, Alice ^a   Lee, I Fang ^a   Akhoundsadegh, Noushin ^a   Ao, Ziliang ^b   Chen, Lieping ^a   Ou, Dawei ^a   Verchere, C Bruce ^a   Warnock, Garth L ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

A Cell functions; B7 H4; Transgenic mice

Indexed keywords

GLUCAGON; INSULIN; STREPTOZOCIN; V SET DOMAIN CONTAINING T CELL ACTIVATION INHIBITOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DIABETES MELLITUS; FLOW CYTOMETRY; GENE INSERTION; GRAFT RECIPIENT; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOHISTOCHEMISTRY; KIDNEY CAPSULE; MOUSE; NONHUMAN; OPEN READING FRAME; ORGAN DONOR; PANCREAS GRAFT REJECTION; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROMOTER REGION; RAT; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE;

ANIMALS; ANTIGENS, CD28; CTLA-4 ANTIGEN; GRAFT SURVIVAL; ISLETS OF LANGERHANS TRANSPLANTATION; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PHENOTYPE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; V-SET DOMAIN-CONTAINING T-CELL ACTIVATION INHIBITOR 1;

EID: 84872077725     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318277229d     Document Type: Article

References (32)

1. Shapiro AM, Lakey JR, Ryan EA, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 27: 230.
2. Warnock GL, Meloche RM, Thompson D, et al. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs best medical therapy in type 1 diabetes mellitus. Arch Surg 2005; 40: 735.
3. Johnson JD, Ao Z, Ao P, et al. Different effects of FK506, rapamycin, and mycophenolate mofetil on glucose-stimulated insulin release and apoptosis in human islets. Cell Transplant 2009; 18: 833.
4. Brissova M, Fowler M, Wiebe P, et al. Intraislet endothelial cells contribute to revascularization of transplanted pancreatic islets. Diabetes 2004; 53: 1318.
5. Linn T, Schmitz J, Hauck-Schmalenberger I, et al. Ischaemia is linked to inflammation and induction of angiogenesis in pancreatic islets. Clin Exp Immunol 2006; 144: 179.
6. Reffet S, Thivolet C. Immunology of pancreatic islet transplantation. Diabetes Metab 2006; 32: 523.
7. Warnock GL, Liao YH, Wang X, et al. An odyssey of islet transplantation for therapy of type 1 diabetes. World J Surg 2007; 31: 1569.
8. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
9. Vincenti F, Larsen C, Durrbach A, et al. Costimulation blockade with belatacept in renal transplantation. N Engl J Med 2005; 25: 353.
10. McGrath MM, Najafian N. The role of coinhibitory signaling pathways in transplantation and tolerance. Front Immunol 2012; 3: 47.
11. Badell IR, Russell MC, Cardona K, et al. CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8. Am J Transplant 2012; 12: 1918.
12. Pestana JO, Grinyo JM, Vanrenterghem Y, et al. Three-year outcomes from BENEFIT-EXT: a phase III study of belatacept versus cyclosporine in recipients of extended criteria donor kidneys. Am J Transplant 2012; 12: 630.
13. Dai H, Zhu H, Lei P, et al. Programmed death-1 signaling is essential for the skin allograft protection by alternatively activated dendritic cell infusion in mice. Transplantation 2009; 88: 864.
14. KleinJan A, Willart MA, Kuipers H, et al. Inducible costimulator blockade prolongs airway luminal patency in a mouse model of obliterative bronchiolitis. Transplantation 2008; 86: 1436.
15. Sucher R, Fischler K, Oberhuber R, et al. IDO and regulatory T cell support are critical for cytotoxic T lymphocyte-associated Ag-4 Igmediated long-term solid organ allograft survival. J Immunol 2012; 188: 37.
16. Sica GL, Choi IH, Zhu G, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003; 18: 849.
17. Prasad DV, Richards S, Mai XM, et al. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003; 8: 863.
18. Zang X, Loke P, Kim J, et al. B7x: a widely expressed B7 family member that inhibits T cell activation. Proc Natl Acad Sci USA 2003; 100: 10388.
19. Ou D, Wang X, Metzger DL, et al. Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathway. Cell Transplant 2006; 15: 399.
20. Wang X, Hao J, Metzger DL, et al. Local expression of B7-H4 by recombinant adenovirus transduction in mouse islets prolongs allograft survival. Transplantation 2009; 87: 482.
21. Wang X, Hao J, Metzger DL, et al. B7-h4 induces donor-specific tolerance in mouse islet allografts. Cell Transplant 2012; 21: 99.
22. Wang X, Hao J, Metzger DL, et al. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune. Diabetes 2011; 60: 3246.
23. Yuan CL, Xu JF, Tong J, et al. B7-H4 transfection prolongs beta-cell graft survival. Transpl Immunol 2009; 21: 143.
24. Yamaura K, Watanabe T, Boenisch O, et al. In vivo function of immune inhibitory molecule B7-H4 in alloimmune responses. Am J Transplant 2010; 10: 2355.
25. Jani M, Hyrich KL. Abatacept in the long-term treatment of rheumatoid arthritis. Expert Rev Clin Immunol 2012; 8: 231.
26. Altmeyer MD, Kerisit KG, Boh EE. Therapeutic hotline. Abatacept: our experience of use in two patients with refractory psoriasis and psoriatic arthritis. Dermatol Ther 2011; 24: 287.
27. Arora S, Tangirala B, Osadchuk L, et al. Belatacept : a new biological agent for maintenance immunosuppression in kidney transplantation. Expert Opin Biol Ther 2012; 12: 965.
28. Suh WK, Wang S, Duncan GS, et al. Generation and characterization of B7-H4/B7S1/B7x-deficient mice. Mol Cell Biol 2006; 26: 6403.
29. Ding Y, Xu J, Bromberg JS. Regulatory T cell migration during an immune response. Trends Immunol 2012; 33: 174.
30. Lee I, Wang L, Wells AD, et al. Recruitment of Foxp3+ T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J Exp Med 2005; 201: 1037.
31. Graca L, Cobbold SP, Waldmann H. Identification of regulatory T cells in tolerated allografts. J Exp Med 2002; 195: 1641.
32. Haasken S, Auger JL, Binstadt BA. Absence of beta2 integrins impairs regulatory T cells and exacerbates CD4+ T cell-dependent autoimmune carditis. J Immunol 2011; 187: 2702.